<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01662089</url>
  </required_header>
  <id_info>
    <org_study_id>SirirajH-004</org_study_id>
    <nct_id>NCT01662089</nct_id>
  </id_info>
  <brief_title>The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement</brief_title>
  <official_title>A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Siriraj Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Zinc supplement is a popular trace element gave to Female pattern hair loss (FPHL) patient.
      But the type of patient, efficacy, and side effect in detail of zinc supplement are not well
      characterized. The purpose of this study is to determine efficacy and side effect of chelated
      zinc in FPHL who using 5%minoxidil solution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5%minoxidil solution is standard treatment for Female pattern hair loss (FPHL) patient. We
      gave 15mg chelate Zinc / Placebo drug to patient as an additional trace element. Then measure
      growth of hair by Global photograph, Microscope hair count, micrometer and record case and
      side effect during 10 months of treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare clinical improvement before and after treatment</measure>
    <time_frame>6 month</time_frame>
    <description>Measure clinical by Global photographic view using 7 point scale. Review picture by 2 dermatologist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare hair density before and after treatmen</measure>
    <time_frame>6 month</time_frame>
    <description>Measure Hair density by microscope photo of area 1 cm2. Conut number of hair in photo.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare average hair shaft diameter before and after treatment</measure>
    <time_frame>6 month</time_frame>
    <description>Compare average hair shaft diameter before and after treatment Measure hair shaft diameter using electronic outside micrometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of pateint with Side effect</measure>
    <time_frame>6 month</time_frame>
    <description>Using side effect record form to record side effect from treatment Count number of pateint with side effect.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Female Pattern Alopecia</condition>
  <arm_group>
    <arm_group_label>Chelate zinc suppliment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15mg Chelate zinc suppliment : additional to standard 5% minoxidil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo drug</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo drug to compare with 15mg chelated Zn : additional to standard 5% minoxidil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>15 mg Chelate zinc supplement</intervention_name>
    <description>15 mg Chelate zinc additional to standard 5% minoxidil</description>
    <arm_group_label>Chelate zinc suppliment</arm_group_label>
    <other_name>zinc, Zn</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo drug supplement</intervention_name>
    <description>Placebo drug instead of Zinc supplement</description>
    <arm_group_label>Placebo drug</arm_group_label>
    <other_name>starch</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female Pattern Hair Loss ( Ludwig classification grade 1 and 2 )

        Exclusion Criteria:

          -  Underlying disease ; Anemia, Diabetes, chronic alcoholism, previous gastrointestinal
             surgery, short bowel syndrome, Crohn's disease, digestive disorder,
             hypo/hyperthyroidism, sickle cell disease, autoimmune disease, iron deficiency

          -  Psychologic disorder trichotillomania

          -  Diet control

          -  Pregnancy or lactation

          -  On supplement diet within 3 month prior to trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rattapon Thuangtong, MD</last_name>
    <phone>+662 419-7000</phone>
    <phone_ext>4333</phone_ext>
    <email>rattapongthuangtong@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rattapon Thuangtong, MD</last_name>
      <phone>+662 419-7000</phone>
      <phone_ext>4333</phone_ext>
      <email>rattapongthuangtong@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2012</study_first_submitted>
  <study_first_submitted_qc>August 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2012</study_first_posted>
  <last_update_submitted>August 7, 2012</last_update_submitted>
  <last_update_submitted_qc>August 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Siriraj Hospital</investigator_affiliation>
    <investigator_full_name>Rattapon Thuangtong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Female pattern hair loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Minoxidil</mesh_term>
    <mesh_term>Chelating Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

